|
MONTHLY TELECONFERENCE
October 14, 2009 9AM |
|
RESOURCES
Read about a simple strategy to screen for kidney disease at Renal Business.com
Check out the eGFR Trending Tool on FMQAI's Website. Click here. |
|
Order FREE Materials
Click on the image.
| |
|
Clinical Labs Report Additional Data to Aid in Detecting Kidney Disease
 The American Clinical Laboratory Association (ACLA), which represents approximately 70% of independent laboratory services throughout the U.S., made a recommendation in May that its members voluntarily calculate an eGFR and report this additional information when doctors order a serum creatinine.
According to the news release by ACLA, six states now mandate that clinical laboratories report eGFR when creatinine is ordered. These states include Louisiana, Michigan, Connecticut, Pennsylvania, New Jersey, and Tennessee.
To read the article, click here. |
|
|
|
Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
 According to an article recently released by FMQAI, "There are currently more than 26 million American adults living with CKD, a number that continues to rise"(National Kidney Foundation.)
A substantial and growing body of evidence has been published confirming the importance of either an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin receptor blocker (ARB) in the treatment or prevention of a number of disease states. Both classes of drugs have been shown to slow the progression of kidney disease by significantly reducing proteinuria, delaying transition from micro- to macroalbuminuria and slowing the decline in glomerular filtration rate American Journal of Kidney Disease.)
The article provides information on dosing, adverse effects, and combination therapy. To read the article, click here. |
|
|
|
USRDS 2009 Annual Data Report
 The United States Renal Data System released its 2009 Annual Data Report today. This years report, the 21st annual for the USRDS, is divided into two volumes: an expanded CKD Atlas, now with 10 chapters covering prevalence in the adult and pediatric population, claims data for CKD care, treatment approaches, morbidity and mortality, transition to ESRD, acute kidney injury, and costs for CKD care; and the Atlas on End-Stage Renal Disease, which contains 12 chapters on ESRD incidence, prevalence, morbidity and mortality, treatment modalities, transplantation, and the costs of ESRD care.
|
|
|
|
Hospital Collaborative Webpage
 The Florida CKD web pages have recently undergone a major update. In addition to the Hospital Collaborative page, the newsroom provides useful articles on CKD. Follow some of the links below for helpful information:
·
Check out the Disparities section for multilingual healthcare and cultural competency information.
·
CKD Continuing Education is a great resource for staff webinars.
·
Resources/Tools/Links offers a multitude of links to organizations with useful information. |
|
The Medicare Quality Improvement Organization for Florida
 FMQAI serves as the Medicare Quality Improvement Organization and End Stage Renal Disease Network (ESRD Network 7) for Florida. With a strong reputation as a leader in facilitating change and collaboration, FMQAI implements projects and conducts case review activities to improve care across all settings, including dialysis and transplant facilities.
| |
